A detailed history of Los Angeles Capital Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 26,092 shares of VCEL stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,092
Previous 26,092 -0.0%
Holding current value
$1.47 Million
Previous $1.2 Million 7.94%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$41.71 - $52.9 $53,180 - $67,447
-1,275 Reduced 4.66%
26,092 $1.2 Million
Q1 2024

Apr 05, 2024

BUY
$32.52 - $52.33 $21,885 - $35,218
673 Added 2.52%
27,367 $1.42 Million
Q3 2023

Nov 06, 2023

SELL
$31.69 - $39.25 $10,996 - $13,619
-347 Reduced 1.28%
26,694 $894,000
Q2 2023

Aug 03, 2023

BUY
$29.0 - $38.37 $784,189 - $1.04 Million
27,041 New
27,041 $1.02 Million
Q2 2021

Aug 05, 2021

SELL
$47.2 - $67.81 $534,162 - $767,405
-11,317 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$30.93 - $59.48 $1.73 Million - $3.32 Million
-55,845 Reduced 83.15%
11,317 $628,000
Q4 2020

Feb 04, 2021

SELL
$18.53 - $31.5 $127,078 - $216,027
-6,858 Reduced 9.27%
67,162 $2.07 Million
Q3 2020

Nov 02, 2020

SELL
$14.68 - $19.12 $507,737 - $661,303
-34,587 Reduced 31.85%
74,020 $1.37 Million
Q2 2020

Aug 05, 2020

BUY
$8.5 - $15.82 $202,665 - $377,196
23,843 Added 28.13%
108,607 $1.5 Million
Q1 2020

May 04, 2020

BUY
$7.25 - $19.22 $614,539 - $1.63 Million
84,764 New
84,764 $777,000
Q1 2019

Apr 25, 2019

SELL
$16.23 - $20.29 $885,752 - $1.11 Million
-54,575 Closed
0 $0
Q4 2018

Feb 11, 2019

SELL
$10.77 - $18.44 $146,418 - $250,691
-13,595 Reduced 19.94%
54,575 $950,000
Q3 2018

Nov 05, 2018

BUY
$9.1 - $14.8 $59,878 - $97,384
6,580 Added 10.68%
68,170 $965,000
Q2 2018

Jul 31, 2018

BUY
$9.6 - $14.6 $591,264 - $899,214
61,590 New
61,590 $597,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.